Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 317,269 | 302,162 | 395,924 | 54,897 | 142,795 |
| Marketable Securities | 545,399 | 560,791 | 505,037 | 503,658 | 411,858 |
| TOTAL | $877,587 | $874,776 | $917,228 | $574,153 | $575,760 |
| Non-Current Assets | |||||
| PPE Net | 11,710 | 12,247 | 11,865 | 10,881 | 9,764 |
| Investments And Advances | 0 | 0 | 0 | 470 | 4,671 |
| Other Non-Current Assets | 48,077 | 48,512 | 49,060 | 49,849 | 51,342 |
| TOTAL | $59,787 | $60,759 | $60,925 | $61,200 | $65,777 |
| Total Assets | $937,374 | $935,535 | $978,153 | $635,353 | $641,537 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,273 | 23,997 | 28,683 | 23,196 | 21,935 |
| Accrued Expenses | 26,191 | 20,375 | 14,829 | 14,517 | 12,877 |
| TOTAL | $53,562 | $54,377 | $51,767 | $43,942 | $40,463 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,685 | 2,560 | 2,463 | 2,056 | 1,662 |
| Other Non-Current Liabilities | 45,637 | 46,075 | 46,712 | 47,555 | 48,182 |
| TOTAL | $50,832 | $50,395 | $51,453 | $52,305 | $53,326 |
| Total Liabilities | $104,394 | $104,772 | $103,220 | $96,247 | $93,789 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 92,738 | 80,036 | 78,860 | 69,596 | 66,799 |
| Common Shares | 1,702,457 | 1,625,640 | 1,595,415 | 1,191,831 | 1,142,218 |
| Retained earnings | -871,515 | -794,687 | -720,632 | -653,702 | -593,605 |
| Other shareholders' equity | 2,038 | -190 | 150 | 977 | -865 |
| TOTAL | $832,980 | $830,763 | $874,933 | $539,106 | $547,748 |
| Total Liabilities And Equity | $937,374 | $935,535 | $978,153 | $635,353 | $641,537 |